Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

LFCR stock hub

Lifecore Biomedical, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LFCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

179.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LFCR

In the news

Latest news · LFCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-0.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LFCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001005286
Company name	Lifecore Biomedical, Inc.
Country	United States
Country code	US
Cusip	514766104
Employees	382
Employees Change	-24%
Employees Change Percent	-5.91
Enterprise value	$305.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US5147661046
Last refreshed	2026-05-10
Market cap	$179.7M
Market cap category	Micro-Cap
Price	$4.79
Price currency	USD
Rev Per Employee	338,912.55x
Sector	Healthcare
Sic	2834
Symbol	LFCR
Website	https://www.lifecore.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.2%
EV Sales Forward	2.45x
EV/EBITDA	37.12x
EV/FCF	49.11x
EV/Sales	2.36x
FCF yield	3.47%
P/B ratio	5.28x
P/S ratio	1.39x
PS Forward	1.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.97%
EBITDA Margin	6.37%
FCF margin	4.81%
Gross margin	31.37%
Gross Profit	$40.6M
Gross Profit Growth	-8.76%
Gross Profit Growth Q	-54.68%
Gross Profit Growth3 Y	5.47%
Gross Profit Growth5 Y	-11.64%
Net Income	$-34.5M
Net Income Growth Years	0%
Pretax Margin	-23.34%
Profit Margin	-23.78%
Profit Per Employee	$-90,323
ROCE	-0.6
ROIC	-0.76
Roic5y	-4.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.14%
Cagr15y	-1.45%
Cagr1y	-31.59%
Cagr20y	-3.01%
Cagr3y	2.87%
Cagr5y	-17.48%
EPS Growth Years	0
OCF Growth	68.24%
OCF Growth Q	291.67%
OCF Growth10 Y	-4.75%
OCF Growth5 Y	18.32%
Revenue Growth	0.8x
Revenue Growth Q	-34.03x
Revenue Growth Years	2x
Revenue Growth3 Y	11.51x
Revenue Growth5 Y	-26.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$232.2M
Cash	$17.5M
Current Assets	$77.6M
Current Liabilities	$20.5M
Debt	$143.7M
Debt EBITDA	$16.83
Debt Equity	$4.22
Debt FCF	$23.07
Equity	$34.1M
Interest Coverage	-0.05
Liabilities	$198.1M
Long Term Assets	$154.5M
Long Term Liabilities	$177.6M
Net Cash	$-126.3M
Net Cash By Market Cap	$-70.27
Net Debt EBITDA	$15.32
Net Debt Equity	$3.71
Net Debt FCF	$20.27
Tangible Book Value	$-32.3M
Tangible Book Value Per Share	$-0.86
WACC	12.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.49
Net Working Capital	$42.6M
Quick ratio	2.18
Working Capital	$58.7M
Working Capital Turnover	$2.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.63%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-57.19%
1Y total return	-31.57%
200-day SMA	6.92
3Y total return	8.86%
50-day SMA	5.13
50-day SMA vs 200-day SMA	50under200
5Y total return	-61.74%
All Time High	20.75
All Time High Change	-76.92%
All Time High Date	1996-05-22
All Time Low	1.51
All Time Low Change	217.22%
All Time Low Date	2002-09-13
ATR	0.31
Beta	1.08
Beta1y	2.61
Beta2y	1.76
Ch YTD	-41.44
High	4.85
High52	8.98
High52 Date	2026-01-27
High52ch	-46.66%
Low	4.67
Low52	3.63
Low52 Date	2026-03-31
Low52ch	32.14%
Ma50ch	-6.54%
Price vs 200-day SMA	-30.77%
RSI	43.56
RSI Monthly	42.36
RSI Weekly	38.24
Sharpe ratio	-0.4x
Sortino ratio	-0.43
Total Return	-1.63%
Tr YTD	-41.44
Tr15y	-19.63%
Tr1m	16.55%
Tr1w	-8.94%
Tr3m	-36.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.28
Earnings Revenue Estimate	26,301,920x
Earnings Revenue Estimate Growth	6.46x
Operating Income	$-1.3M
Operating margin	-0.97
Price target	$6
Price Target Change	$25.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,835,264%
Float Percent	52.88%
Net Borrowing	-4,285,715
Shares Insiders	2.04%
Shares Institutions	31.18%
Shares Out	37,509,407
Shares Qo Q	0.02%
Shares Yo Y	1.63%
Short Float	13.37%
Short Ratio	4.34
Short Shares	7.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.5M
Average Volume	224,848.35x
Bv Per Share	-0.38
CAPEX	$-6.3M
Ch10y	-57.19
Ch15y	-19.63
Ch1m	16.55
Ch1w	-8.94
Ch1y	-31.57
Ch20y	-45.69
Ch3m	-36.72
Ch3y	8.86
Ch5y	-61.74
Ch6m	-30.07
Change	0.42%
Change From Open	1.27
Close	4.77
Days Gap	-0.84
Depreciation Amortization	9,498,859
Dollar Volume	983,003.8
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-1.3M
EBITDA	$8.2M
EPS	$-0.93
F Score	3
FCF	$6.2M
FCF EV Yield	2.04x
FCF Per Share	$0.17
Financing CF	-7,594,287
Fiscal Year End	December
Founded	1,986
Goodwill	13,881,000
Income Tax	$577,714
Investing CF	10,806,859
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2025-08-07
Ma150	6.75
Ma150ch	-29.01%
Ma20	5.11
Ma20ch	-6.21%
Net CF	15,778,288
Next Earnings Date	2026-08-06
Open	4.73
Optionable	Yes
P FCF Ratio	28.84
P OCF Ratio	14.3
Position In Range	66.67
Post Close	4.79
Postmarket Change Percent	-3.97
Postmarket Price	$4.6
Ppne	125,513,000
Price Date	2026-05-08
Price EBITDA	$21.8
Relative Volume	0.91x
Revenue	129,464,593x
SBC By Revenue	7.51x
Share Based Comp	9,721,716
Tax By Revenue	0.45x
Tr20y	-45.69%
Tr6m	-30.07%
Us State	Minnesota
Volume	205,220
Z Score	0.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LFCR pay a dividend?

Capital-return profile for this ticker.

Performance

LFCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LFCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.2%

Float: +52.9% of shares outstanding

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LFCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

-30.8%

50/200-day relationship not available

Beta (5Y)

1.08

Moves roughly with the market

Sharpe ratio

-0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LFCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LFCR stock rating?

Lifecore Biomedical, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LFCR analysis?

The full report lives at /stocks/LFCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LFCR?

The latest report frames LFCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LFCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.